EXECUTIVE SUMMARY

i.    European Market for Oral Drug Delivery Products

a.   Diffusion-Controlled Systems

b.   Solvent-Activated Systems

c.    Chemically Controlled Systems

d.   Regulated Systems

e.   Closed-Loop Systems

f.    Multiparticulate Systems

g.   Technological Advances

h.   Market Analysis

ii.    European Market for Transdermal Drug Delivery Products

a.   Single-Layer Drug-in-Adhesive

b.   Multilayer Drug-in-Adhesive

c.    Reservoir

d.   Matrix

e.   Technological Advances

f.    Market Analysis

iii.   European Market for Inhalation Drug Delivery Products

a.   Metered Dose Inhalers

b.   Dry Powder Inhalers

c.    Nebulizer Inhalers

d.   Liquid-Based Inhalers

e.   Technological Advances

f.    Market Analysis

iv.   European Market for Transmucosal Drug Delivery Products

a.   Buccal/Sublingual

b.   Nasal

c.    Ocular

d.   Vaginal

e.   Market Analysis

v.   European Market for Injectable Drug Delivery Products

a.   Injection Drug Delivery Products

b.   Infusion Drug Delivery Products

c.    Market Analysis

vi.   Combined Market Analysis

 

Exhibit ES-1:    Europe, Oral Drug Delivery Products, Market Forecast, by Country, 2007-2013  ES-8

Exhibit ES-2:    Europe, Transdermal Drug Delivery Systems, Market Forecast, by Country, 2007-2013

Exhibit ES-3:    Europe, Inhalation Drug Delivery Products, Market Forecast, by Country, 2007-2013

Exhibit ES-4:    Europe, Transmucosal Drug Delivery Products, Market Forecast, by Country, 2007-2013

Exhibit ES-5:    Europe, Injectable Drug Delivery Products, Market Forecast, by Country, 2007-2013

Exhibit ES-6:    Europe, Sales of Drug Delivery Products, by Market Segment, 2007 and 2013

Exhibit ES-7:    Europe, Drug Delivery Products, Combined Market Forecast, by Country, 2007-2013

 

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union

1.1.1 A Common Currency

1.1.2 Regulatory Policies

1.1.3 Reimbursement

1.1.4 Healthcare Spending

1.2 Selected European National Healthcare Profiles

1.2.1 France

1.2.1.1 Healthcare Organization and Reform

1.2.1.2 Hospital Services

1.2.1.3 Medical Device Reimbursement

1.2.2 Germany

1.2.2.1 Healthcare Organization and Reform

1.2.2.2 Hospital Services

1.2.2.3 Medical Device Reimbursement

1.2.3 Italy

1.2.3.1 Healthcare Organization and Reform

1.2.3.2 Hospital Services

1.2.3.3 Medical Device Reimbursement

1.2.4 Spain

1.2.4.1 Healthcare Organization and Reform

1.2.4.2 Hospital Services

1.2.4.3 Medical Device Reimbursement

1.2.5 United Kingdom

1.2.5.1 Healthcare Organization and Reform

1.2.5.2 Hospital Services

1.2.5.3 Medical Device Reimbursement

1.2.6 Benelux

1.2.6.1 Healthcare Organization and Reform

1.2.6.1.1 Belgium

1.2.6.1.2 Luxembourg

1.2.6.1.3 The Netherlands

1.2.6.2 Hospital Services

1.2.6.3 Medical Device Reimbursement

1.2.7 Nordic Countries

1.2.7.1 Healthcare Organization and Reform

1.2.7.1.1 Denmark

1.2.7.1.2 Finland

1.2.7.1.3 Norway

1.2.7.1.4 Sweden

1.2.7.2 Hospital Services

1.2.7.3 Medical Device Reimbursement

 

Exhibit 1-1:      European Union, Medical Devices Risk Classification System

Exhibit 1-2:      European Union Population Statistics Comparison for the Years 1996, 2006, and 2016

Exhibit 1-3:      France, Selected National Healthcare Statistics

Exhibit 1-4:      Germany, Selected National Healthcare Statistics

Exhibit 1-5:      Italy, Selected National Healthcare Statistics

Exhibit 1-6:      Spain, Selected National Healthcare Statistics

Exhibit 1-7:      United Kingdom, Selected National Healthcare Statistics

Exhibit 1-8:      Belgium, Selected National Healthcare Statistics

Exhibit 1-9:      Luxembourg, Selected National Healthcare Statistics

Exhibit 1-10:    The Netherlands, Selected National Healthcare Statistics

Exhibit 1-11:    Denmark, Selected National Healthcare Statistics

Exhibit 1-12:    Finland, Selected National Healthcare Statistics

Exhibit 1-13:    Norway, Selected National Healthcare Statistics

Exhibit 1-14:    Sweden, Selected National Healthcare Statistics

 

2. OVERVIEW OF DRUG DELIVERY

2.1 Current Developments

2.2 Pharmacokinetics

2.2.1 Drug Absorption

2.2.1.1 Transportation Across Cell Membranes

2.2.1.1.1 Active Transport

2.2.1.1.2 Facilitated Passive Diffusion

2.2.1.1.3 Passive Diffusion

2.2.1.1.4 Pinocytosis

2.2.1.2 Oral Drug Delivery

2.2.1.3 Parenteral Drug Delivery

2.2.1.4 Transdermal Drug Delivery

2.2.1.5 Inhalation Drug Delivery

2.2.2 Drug Distribution

2.2.3 Drug Metabolism

2.2.3.1 Enzyme Induction

2.2.3.2 Enzyme Inhibition

2.2.3.3 Factors Affecting Metabolism

2.2.4 Drug Elimination

2.2.4.1 Metabolism

2.2.4.2 Excretion

2.3 Pharmacodynamics

2.3.1 Agonists and Antagonists

 

Exhibit 2-1:      Relationship Between Pharmacokinetics and Pharmacodynamics

Exhibit 2-2:      Routes for Parenteral Drug Delivery

Exhibit 2-3:      Advantages and Disadvantages of Transdermal Drug Delivery

Exhibit 2-4:      Biochemical Pathway for Oxidative Drug Metabolism

Exhibit 2-5:      Examples of Physiologic and Drug-Receptor Proteins

 

3. EUROPEAN MARKET FOR ORAL DRUG DELIVERY PRODUCTS

3.1 Controlled-Release Oral Drug Delivery Systems

3.1.1 Diffusion-Controlled Systems

3.1.1.1 Reservoir Systems

3.1.1.2 Monolithic Systems

3.1.2 Solvent-Activated Systems

3.1.2.1 Hydrophilic Matrix Tablets

3.1.2.2 Osmotically Controlled Systems

3.1.3 Chemically Controlled Systems

3.1.3.1 Biodegradable Systems

3.1.3.2 Covalent Polymer-Drug Conjugate Systems

3.1.4 Regulated Systems

3.1.4.1 Magnetically Controlled Systems

3.1.4.2 Ultrasound-Controlled Systems

3.1.4.3 Orally Disintegrating Systems

3.1.5 Closed-Loop Systems

3.1.6 Multiparticulate Systems

3.1.7 Advances in Oral Drug Delivery Technologies

3.1.7.1 Prodrugs

3.1.7.2 Pulsatile Systems

3.1.7.3 Liposomes

3.2 Products and Technologies

3.3 Market Analysis

3.3.1 Market Drivers

3.3.2 Market Limiters

3.3.3 Market Forecast

3.3.4 Competitive Analysis

 

Exhibit 3-1:      Advantages and Disadvantages of Controlled-Release Oral Drug Delivery Products

Exhibit 3-2:      Reservoir-Based Diffusion-Controlled Drug Delivery

Exhibit 3-3:      Advantages and Disadvantages of Reservoir-Based Diffusion-Controlled Drug Delivery Systems

Exhibit 3-4:      Monolithic Diffusion-Controlled Drug Delivery

Exhibit 3-5:      2008, Selected Polymers Used in Matrix/Coating Oral Drug Delivery Products

Exhibit 3-6:      OROS Osmotic Technology

Exhibit 3-7:      Advantages of Osmotic Drug Delivery Systems

Exhibit 3-8:      Ultrasound-Controlled Drug Delivery

Exhibit 3-9:      Advantages of Orally Disintegrating Drug Delivery Systems

Exhibit 3-10:    2008, Selected Orally Disintegrating Drug Delivery Systems

Exhibit 3-11:    Advantages and Disadvantages of Multiparticulate Drug Delivery Systems

Exhibit 3-12:    2008, Selected Types of Pulsatile Drug Delivery Systems

Exhibit 3-13:    2008, Selected Oral Drug Delivery Systems

Exhibit 3-14:    Europe, Oral Drug Delivery Products, Market Forecast, by Country, 2007-2013

Exhibit 3-15:    2007, Europe, Oral Drug Delivery Products Market, Share by Supplier

Exhibit 3-16:    2007, France, Oral Drug Delivery Products Market, Share by Supplier

Exhibit 3-17:    2007, Germany, Oral Drug Delivery Products Market, Share by Supplier

Exhibit 3-18:    2007, Italy, Oral Drug Delivery Products Market, Share by Supplier

Exhibit 3-19:    2007, Spain, Oral Drug Delivery Products Market, Share by Supplier

Exhibit 3-20:    2007, United Kingdom, Oral Drug Delivery Products Market, Share by Supplier

Exhibit 3-21:    2007, Benelux Countries, Oral Drug Delivery Products Market, Share by Supplier

Exhibit 3-22:    2007, Nordic Countries, Oral Drug Delivery Products Market, Share by Supplier

Exhibit 3-23:    2007, Rest of Europe, Oral Drug Delivery Products Market, Share by Supplier

 

4. EUROPEAN MARKET FOR TRANSDERMAL DRUG DELIVERY PRODUCTS

4.1 Anatomy and Physiology of the Skin

4.2 Types of Transdermal Drug Delivery Systems

4.2.1 Single-Layer Drug-in-Adhesive

4.2.2 Multilayer Drug-in-Adhesive

4.2.3 Reservoir

4.2.4 Matrix

4.2.5 Basic Components of Transdermal Drug Delivery Systems

4.2.5.1 Backing Films

4.2.5.2 Release Liners

4.2.5.3 Pressure-Sensitive Adhesives

4.2.5.4 Active Ingredient(s)

4.2.5.5 Penetration Enhancers

4.2.5.6 Semipermeable Membranes

4.2.5.7 Pouching Materials

4.3 Technological Advances

4.3.1 Chemical Permeation Enhancers

4.3.2 Physical Permeation Enhancers

4.3.2.1 Electrical Methods

4.3.2.1.1 Electroporation

4.3.2.1.2 Iontophoresis

4.3.2.2 Mechanical Methods

4.3.2.2.1 Abrasion

4.3.2.2.2 Microneedle Puncture

4.3.2.2.3 Needleless Injection

4.3.2.3 Other Methods

4.3.2.3.1 Laser and Photomechanical Waves

4.3.2.3.2 Magnetophoresis

4.3.2.3.3 Noninvasive Radiofrequency-Enhanced Drug Delivery

4.3.2.3.4 Sonophoresis

4.3.2.3.5 Thermal-Assisted Transdermal Drug Delivery

4.4 Products and Technologies

4.5 Market Analysis

4.5.1 Market Drivers

4.5.2 Market Limiters

4.5.3 Market Forecast

4.5.4 Competitive Analysis

 

Exhibit 4-1:      Advantages and Disadvantages of Transdermal Drug Delivery

Exhibit 4-2:      Anatomy of the Skin

Exhibit 4-3:      Single-Layer Drug-in-Adhesive Transdermal Drug Delivery

Exhibit 4-4:      Multilayer Drug-in-Adhesive Transdermal Drug Delivery

Exhibit 4-5:      Reservoir Transdermal Drug Delivery

Exhibit 4-6:      Matrix Transdermal Drug Delivery

Exhibit 4-7:      Advantages and Disadvantages of Pressure-Sensitive Adhesives Used in Transdermal Drug Delivery Systems

Exhibit 4-8:      Classification of Physical Permeation Enhancement Methods

Exhibit 4-9:      Electroporation Enhancement of Transdermal Drug Delivery

Exhibit 4-10:    Iontophoresis Enhancement of Transdermal Drug Delivery

Exhibit 4-11:    Microneedle Delivery Devices for Transdermal Drug Delivery

Exhibit 4-12:    PowderMed’s Needleless Particle-Mediated Epidermal Delivery Device

Exhibit 4-13:    Ultrasound-Enhanced Transdermal Drug Delivery

Exhibit 4-14:    2009, Selected Transdermal Drug Delivery Systems

Exhibit 4-15:    2007, Europe, Sales of Transdermal Drug Delivery Systems, by Segment

Exhibit 4-16:    Europe, Transdermal Drug Delivery Systems, Market Forecast, by Country, 2007-2013

Exhibit 4-17:    2007, Europe, Transdermal Drug Delivery Systems Market, Share by Supplier

Exhibit 4-18:    2007, France, Transdermal Drug Delivery Systems Market, Share by Supplier

Exhibit 4-19:    2007, Germany, Transdermal Drug Delivery Systems Market, Share by Supplier

Exhibit 4-20:    2007, Italy, Transdermal Drug Delivery Systems Market, Share by Supplier

Exhibit 4-21:    2007, Spain, Transdermal Drug Delivery Systems Market, Share by Supplier

Exhibit 4-22:    2007, United Kingdom, Transdermal Drug Delivery Systems Market, Share by Supplier

Exhibit 4-23:    2007, Benelux Countries, Transdermal Drug Delivery Systems Market, Share by Supplier

Exhibit 4-24:    2007, Nordic Countries, Transdermal Drug Delivery Systems Market, Share by Supplier

Exhibit 4-25:    2007, Rest of Europe, Transdermal Drug Delivery Systems Market, Share by Supplier

 

5. EUROPEAN MARKET FOR INHALATION DRUG DELIVERY PRODUCTS

5.1 Anatomy and Physiology of the Respiratory System

5.2 Physiochemical Principles in Inhalation Drug Delivery

5.3 Types of Inhalation Drug Delivery Systems

5.3.1 Metered Dose Inhalers

5.3.2 Dry Powder Inhalers

5.3.3 Nebulizer Inhalers

5.3.4 Liquid-Based Inhalers

5.3.5 Emerging Developments

5.3.5.1 Inhaled Gene Therapy

5.3.5.2 Inhaled Liposomes

5.3.5.3 Inhaled Systemic Drugs

5.3.5.4 Inhaled Vaccines

5.3.5.5 Piezo-Electronic Inhalers

5.4 Formulation Components

5.4.1 Metered Dose Inhaler Formulation Components

5.4.1.1 Solution Formulations

5.4.1.2 Suspension Propellant Formulations

5.4.2 Dry Powder Inhaler Formulation Components

5.4.2.1 Adhesive Mixture Formulations

5.4.2.2 Soft Spherical Pellet Formulations

5.5 Products and Technologies

5.6 Market Analysis

5.6.1 Market Drivers

5.6.2 Market Limiters

5.6.3 Market Forecast, Metered Dose Inhalers

5.6.3.1 Competitive Analysis

5.6.4 Market Forecast, Dry Powder Inhalers

5.6.4.1 Competitive Analysis

5.6.5 Market Forecast, Nebulizer Inhalers

5.6.5.1 Competitive Analysis

5.6.6 Market Forecast, Liquid-Based Inhalers

5.6.6.1 Competitive Analysis

5.6.7 Combined Market Forecast

5.6.7.1 Combined Competitive Analysis

 

Exhibit 5-1:      Evolution of Pulmonary Drug Delivery Devices

Exhibit 5-2:      Advantages of Pulmonary Drug Delivery

Exhibit 5-3:      Simple Diagram of the Lung Structure

Exhibit 5-4:      The Physiology of Gas Exchange

Exhibit 5-5:      Advantages and Disadvantages of Pressurized Metered Dose Inhalers

Exhibit 5-6:      Mechanism of a Pressurized Metered Dose Inhaler

Exhibit 5-7:      Advantages and Disadvantages of Dry Powder Inhalers

Exhibit 5-8:      Advantages and Disadvantages of Nebulizer Inhalers

Exhibit 5-9:      Piezo-Electronic Inhaler Technology

Exhibit 5-10:    2009, Selected Metered Dose Inhalers

Exhibit 5-11:    2009, Selected Dry Powder Inhalers

Exhibit 5-12:    2009, Selected Nebulizer Inhalers

Exhibit 5-13:    2009, Selected Liquid-Based Inhalers

Exhibit 5-14:    Europe, Metered Dose Inhalers, Market Forecast, by Country, 2007-2013

Exhibit 5-15:    2007, Europe, Metered Dose Inhalers Market, Share by Supplier

Exhibit 5-16:    2007, France, Metered Dose Inhalers Market, Share by Supplier

Exhibit 5-17:    2007, Germany, Metered Dose Inhalers Market, Share by Supplier

Exhibit 5-18:    2007, Italy, Metered Dose Inhalers Market, Share by Supplier

Exhibit 5-19:    2007, Spain, Metered Dose Inhalers Market, Share by Supplier

Exhibit 5-20:    2007, United Kingdom, Metered Dose Inhalers Market, Share by Supplier

Exhibit 5-21:    2007, Benelux Countries, Metered Dose Inhalers Market, Share by Supplier

Exhibit 5-22:    2007, Nordic Countries, Metered Dose Inhalers Market, Share by Supplier

Exhibit 5-23:    2007, Rest of Europe, Metered Dose Inhalers Market, Share by Supplier

Exhibit 5-24:    Europe, Dry Powder Inhalers, Market Forecast, by Country, 2007-2013

Exhibit 5-25:    2007, Europe, Dry Powder Inhalers Market, Share by Supplier

Exhibit 5-26:    2007, France, Dry Powder Inhalers Market, Share by Supplier

Exhibit 5-27:    2007, Germany, Dry Powder Inhalers Market, Share by Supplier

Exhibit 5-28:    2007, Italy, Dry Powder Inhalers Market, Share by Supplier

Exhibit 5-29:    2007, Spain, Dry Powder Inhalers Market, Share by Supplier

Exhibit 5-30:    2007, United Kingdom, Dry Powder Inhalers Market, Share by Supplier

Exhibit 5-31:    2007, Benelux Countries, Dry Powder Inhalers Market, Share by Supplier

Exhibit 5-32:    2007, Nordic Countries, Dry Powder Inhalers Market, Share by Supplier

Exhibit 5-33:    2007, Rest of Europe, Dry Powder Inhalers Market, Share by Supplier

Exhibit 5-34:    Europe, Nebulizer Inhalers, Market Forecast, by Country, 2007-2013

Exhibit 5-35:    2007, Europe, Nebulizer Inhalers Market, Share by Supplier

Exhibit 5-36:    2007, France, Nebulizer Inhalers Market, Share by Supplier

Exhibit 5-37:    2007, Germany, Nebulizer Inhalers Market, Share by Supplier

Exhibit 5-38:    2007, Italy, Nebulizer Inhalers Market, Share by Supplier

Exhibit 5-39:    2007, Spain, Nebulizer Inhalers Market, Share by Supplier

Exhibit 5-40:    2007, United Kingdom, Nebulizer Inhalers Market, Share by Supplier

Exhibit 5-41:    2007, Benelux Countries, Nebulizer Inhalers Market, Share by Supplier

Exhibit 5-42:    2007, Nordic Countries, Nebulizer Inhalers Market, Share by Supplier

Exhibit 5-43:    2007, Rest of Europe, Nebulizer Inhalers Market, Share by Supplier

Exhibit 5-44:    Europe, Liquid-Based Inhalers, Market Forecast, by Country, 2007-2013

Exhibit 5-45:    2007, Europe, Liquid-Based Inhalers Market, Share by Supplier

Exhibit 5-46:    2007, France, Liquid-Based Inhalers Market, Share by Supplier

Exhibit 5-47:    2007, Germany, Liquid-Based Inhalers Market, Share by Supplier

Exhibit 5-48:    2007, Italy, Liquid-Based Inhalers Market, Share by Supplier

Exhibit 5-49:    2007, Spain, Liquid-Based Inhalers Market, Share by Supplier

Exhibit 5-50:    2007, United Kingdom, Liquid-Based Inhalers Market, Share by Supplier

Exhibit 5-51:    2007, Benelux Countries, Liquid-Based Inhalers Market, Share by Supplier

Exhibit 5-52:    2007, Nordic Countries, Liquid-Based Inhalers Market, Share by Supplier

Exhibit 5-53:    2007, Rest of Europe, Liquid-Based Inhalers Market, Share by Supplier

Exhibit 5-54:    Europe, Sales of Inhalation Drug Delivery Products, by Market Segment, 2007 and 2013

Exhibit 5-55:    Europe, Inhalation Drug Delivery Products, Combined Market Forecast, by Country, 2007-2013

Exhibit 5-56:    2007, Europe, Combined Inhalation Drug Delivery Products Market, Share by Supplier

Exhibit 5-57:    2007, France, Combined Inhalation Drug Delivery Products Market, Share by Supplier

Exhibit 5-58:    2007, Germany, Combined Inhalation Drug Delivery Products Market, Share by Supplier

Exhibit 5-59:    2007, Italy, Combined Inhalation Drug Delivery Products Market, Share by Supplier

Exhibit 5-60:    2007, Spain, Combined Inhalation Drug Delivery Products Market, Share by Supplier

Exhibit 5-61:    2007, United Kingdom, Combined Inhalation Drug Delivery Products Market, Share by Supplier

Exhibit 5-62:    2007, Benelux Countries, Combined Inhalation Drug Delivery Products Market, Share by Supplier

Exhibit 5-63:    2007, Nordic Countries, Combined Inhalation Drug Delivery Products Market, Share by Supplier

Exhibit 5-64:    2007, Rest of Europe, Combined Inhalation Drug Delivery Products Market, Share by Supplier

 

6. EUROPEAN MARKET FOR TRANSMUCOSAL DRUG DELIVERY PRODUCTS

6.1 Types

6.1.1 Buccal and Sublingual Drug Delivery

6.1.2 Nasal Drug Delivery

6.1.3 Ocular Drug Delivery

6.1.3.1 Liquids

6.1.3.2 Solids

6.1.3.3 Semisolids

6.1.3.4 Other

6.1.4 Vaginal Drug Delivery

6.2 Products and Technologies

6.3 Market Analysis

6.3.1 Market Drivers

6.3.2 Market Limiters

6.3.3 Market Forecast

6.3.4 Competitive Analysis

 

Exhibit 6-1:      Advantages and Disadvantages of Nasal Drug Delivery

Exhibit 6-2:      Advantages of Ocular Insert Drug Delivery

Exhibit 6-3:      Advantages of Vaginal Drug Delivery

Exhibit 6-4:      2008, Selected Nasal Drug Delivery Products

Exhibit 6-5:      2008, Selected Buccal and Sublingual Drug Delivery Products

Exhibit 6-6:      2008, Selected Ocular Drug Delivery Products

Exhibit 6-7:      2008, Selected Vaginal Drug Delivery Products

Exhibit 6-8:      Europe, Transmucosal Drug Delivery Products, Market Forecast, by Country, 2007-2013

Exhibit 6-9:      2007, Europe, Transmucosal Drug Delivery Products Market, Share by Supplier

Exhibit 6-10:    2007, France, Transmucosal Drug Delivery Products Market, Share by Supplier

Exhibit 6-11:    2007, Germany, Transmucosal Drug Delivery Products Market, Share by Supplier

Exhibit 6-12:    2007, Italy, Transmucosal Drug Delivery Products Market, Share by Supplier

Exhibit 6-13:    2007, Spain, Transmucosal Drug Delivery Products Market, Share by Supplier

Exhibit 6-14:    2007, United Kingdom, Transmucosal Drug Delivery Products Market, Share by Supplier

Exhibit 6-15:    2007, Benelux Countries, Transmucosal Drug Delivery Products Market, Share by Supplier

Exhibit 6-16:    2007, Nordic Countries, Transmucosal Drug Delivery Products Market, Share by Supplier

Exhibit 6-17:    2007, Rest of Europe, Transmucosal Drug Delivery Products Market, Share by Supplier

 

7. EUROPEAN MARKET FOR INJECTABLE DRUG DELIVERY PRODUCTS

7.1 Types of Injection Drug Delivery

7.1.1 Intramuscular Injection

7.1.2 Subcutaneous Injection

7.1.3 Classification of Injection Devices

7.2 Types of Infusion Drug Delivery

7.2.1 Intraoperative Site Infusion

7.2.2 Intraspinal Infusion

7.2.3 Intravenous Infusion

7.2.4 External Infusion Pumps

7.2.4.1 Gravity-Controlled Pumps

7.2.4.2 Positive Displacement Pumps

7.2.4.2.1 Volumetric Infusion Pumps

7.2.4.2.2 Syringe Infusion Pumps

7.2.4.2.3 Patient-Controlled Analgesia Infusion Pumps

7.2.4.2.4 Ambulatory Pumps

7.2.4.2.5 Disposable Infusion Pumps

7.2.5 Implantable Infusion Pumps

7.3 Injection Drug Delivery, Products and Technologies

7.4 Infusion Drug Delivery, Products and Technologies

7.5 Market Analysis

7.5.1 Market Drivers

7.5.2 Market Limiters

7.5.3 Market Forecast, Injection Drug Delivery Devices

7.5.3.1 Competitive Analysis

7.5.4 Market Forecast, Infusion Drug Delivery Products

7.5.4.1 Competitive Analysis

7.5.5 Combined Market Forecast

7.5.5.1 Combined Competitive Analysis

 

Exhibit 7-1:      Advantages and Disadvantages of Syringe Pumps

Exhibit 7-2:      Advantages and Disadvantages of Patient-Controlled Analgesia Infusion Pumps

Exhibit 7-3:      Advantages and Disadvantages of Disposable Infusion Pumps

Exhibit 7-4:      2009, Selected Disposable Safety Syringes

Exhibit 7-5:      2009, Selected Prefilled Syringes

Exhibit 7-6:      2009, Selected Insulin Pen Injectors

Exhibit 7-7:      2009, Selected Needle-Free Liquid Jet Injectors

Exhibit 7-8:      2009, Selected Hypodermic Needles and Syringes

Exhibit 7-9:      2009, Selected Insulin Infusion Pumps

Exhibit 7-10:    2009, Selected Syringe Infusion Pumps

Exhibit 7-11:    2009, Selected Volumetric Infusion Pumps

Exhibit 7-12:    2009, Selected Patient-Controlled Analgesia Infusion Pumps

Exhibit 7-13:    2009, Selected Ambulatory Infusion Pumps

Exhibit 7-14:    2009, Selected Constant-Flow Implantable Infusion Pumps

Exhibit 7-15:    2009, Selected Programmable Implantable Infusion Pumps

Exhibit 7-16:    Europe, Injection Drug Delivery Products, Market Forecast, by Country, 2007-2013

Exhibit 7-17:    2007, Europe, Injection Drug Delivery Products Market, Share by Supplier

Exhibit 7-18:    2007, France, Injection Drug Delivery Products Market, Share by Supplier

Exhibit 7-19:    2007, Germany, Injection Drug Delivery Products Market, Share by Supplier

Exhibit 7-20:    2007, Italy, Injection Drug Delivery Products Market, Share by Supplier

Exhibit 7-21:    2007, Spain, Injection Drug Delivery Products Market, Share by Supplier

Exhibit 7-22:    2007, United Kingdom, Injection Drug Delivery Products Market, Share by Supplier

Exhibit 7-23:    2007, Benelux Countries, Injection Drug Delivery Products Market, Share by Supplier

Exhibit 7-24:    2007, Nordic Countries, Injection Drug Delivery Products Market, Share by Supplier

Exhibit 7-25:    2007, Rest of Europe, Injection Drug Delivery Products Market, Share by Supplier

Exhibit 7-26:    Europe, Infusion Drug Delivery Products, Market Forecast, by Country, 2007-2013

Exhibit 7-27:    2007, Europe, Infusion Drug Delivery Products Market, Share by Supplier

Exhibit 7-28:    2007, France, Infusion Drug Delivery Products Market, Share by Supplier

Exhibit 7-29:    2007, Germany, Infusion Drug Delivery Products Market, Share by Supplier

Exhibit 7-30:    2007, Italy, Infusion Drug Delivery Products Market, Share by Supplier

Exhibit 7-31:    2007, Spain, Infusion Drug Delivery Products Market, Share by Supplier

Exhibit 7-32:    2007, United Kingdom, Infusion Drug Delivery Products Market, Share by Supplier

Exhibit 7-33:    2007, Benelux Countries, Infusion Drug Delivery Products Market, Share by Supplier

Exhibit 7-34:    2007, Nordic Countries, Infusion Drug Delivery Products Market, Share by Supplier

Exhibit 7-35:    2007, Rest of Europe, Infusion Drug Delivery Products Market, Share by Supplier

Exhibit 7-36:    Europe, Injectable Drug Delivery Products, Combined Market Forecast, by Country, 2007-2013

Exhibit 7-37:    2007, Europe, Combined Injectable Drug Delivery Products Market, Share by Supplier

Exhibit 7-38:    2007, France, Combined Injectable Drug Delivery Products Market, Share by Supplier

Exhibit 7-39:    2007, Germany, Combined Injectable Drug Delivery Products Market, Share by Supplier

Exhibit 7-40:    2007, Italy, Combined Injectable Drug Delivery Products Market, Share by Supplier

Exhibit 7-41:    2007, Spain, Combined Injectable Drug Delivery Products Market, Share by Supplier

Exhibit 7-42:    2007, United Kingdom, Combined Injectable Drug Delivery Products Market, Share by Supplier

Exhibit 7-43:    2007, Benelux Countries, Combined Injectable Drug Delivery Products Market, Share by Supplier

Exhibit 7-44:    2007, Nordic Countries, Combined Injectable Drug Delivery Products Market, Share by Supplier

Exhibit 7-45:    2007, Rest of Europe, Combined Injectable Drug Delivery Products Market, Share by Supplier

 

 

8. COMPANY PROFILES

8.1       3M Health Care, Inc./3M Company

8.2       AstraZeneca PLC

8.3       Baxter International, Inc.

8.4       B. Braun Melsungen AG

8.5       Becton, Dickinson and Company

8.6       Biovail Corporation

8.7       Boehringer Ingelheim GmbH

8.8       Cardinal Health, Inc.

8.9       Elan Corporation PLC

8.10     Fresenius SE

8.11     GlaxoSmithKline PLC

8.12     Johnson & Johnson

8.13     Novartis AG

8.14     Noven Pharmaceuticals, Inc.

8.15     Terumo Europe NV/Terumo Corporation

 

APPENDIX: COMPANY LISTING